Ajay Major, Assistant Professor of Medicine at the University of Colorado School of Medicine, shared a post on X:
“Prior benda in EPCORE NHL-1 Tycel Phillips ASH24:
– 27% of trial pts w/ prior benda.
– no diff in ORR (59.5 vs 62.7%) w or w/o benda.
– also no diff PFS (4.4 mo both), CRS or ICANS .
– no effect on cytotoxic T cells.
Now seen in multiple series.”
Ajay Major is an Assistant Professor of Medicine at the University of Colorado School of Medicine, specializing in lymphoma and CLL/SLL. He is the Founder and President of Pager Publications, as well as the Founder and Editor-in-Chief of in-House. Additionally, he serves as a Reviewer for the Bellevue Literary Review.